Harpoon Therapeutics, Inc. 4/A SEC Filings

Filed On	Filing
14 May 2021	Form 4/A: Colowick Alan, Director Holds 0 Director Stock Option (Right to Buy) (exercise price $22.50, expires May 3, 2031)
14 May 2021	Form 4/A: Viney Joanne L., Director Granted 12,738 Director Stock Option (Right to Buy)
14 May 2021	Form 4/A: Bailes Joseph S, Director Granted 10,167 Director Stock Option (Right to Buy)
14 May 2021	Form 4/A: Robbins Andrew R, Director Granted 10,167 Director Stock Option (Right to Buy)
14 May 2021	Form 4/A: Myers Scott Dunseth, Director Granted 10,167 Director Stock Option (Right to Buy)
14 May 2021	Form 4/A: Eastland Julia Marie, Director Granted 10,167 Director Stock Option (Right to Buy)
14 May 2021	Form 4/A: Hunt Ronald, Director Granted 14,825 Director Stock Option (Right to Buy)
14 May 2021	Form 4/A: Drachman Jonathan G, Director Granted 10,167 Director Stock Option (Right to Buy)
14 May 2021	Form 4/A: Chin Mark, Director Granted 12,605 Director Stock Option (Right to Buy)
29 Mar 2019	Form 4/A: Hunt Ronald, Director Granted 4,923 Director Stock Option (Right to Buy)
29 Mar 2019	Form 4/A: Evnin Luke, Director Granted 7,658 Director Stock Option (Right to Buy)
29 Mar 2019	Form 4/A: Chin Mark, Director Granted 6,071 Director Stock Option (Right to Buy)

Comments